Yan, Huijiao
Ren, Wenhui
Jia, Mengmeng
Xue, Peng
Li, Zhifang
Zhang, Shaokai
He, Lichun
Qiao, Youlin
Funding for this research was provided by:
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (CIFMS 2017-I2M-B&R-03, CIFMS 2017-I2M-B&R-03, CIFMS 2017-I2M-B&R-03, CIFMS 2017-I2M-B&R-03, CIFMS 2017-I2M-B&R-03, CIFMS 2017-I2M-B&R-03, CIFMS 2017-I2M-B&R-03)
China Postdoctoral Science Foundation (2021T140068)
Article History
Received: 14 January 2023
Accepted: 25 September 2023
First Online: 9 October 2023
Declarations
:
: This study was approved by the institutional review board of the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Sciences (IRB approval number 19/109–1893). And the ethics committees of each participating hospitals were approved this study. All methods were performed in accordance with the ethical standards of the Institutional Review of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Sciences, all participant hospitals, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all participants.
: Consent for publication was obtained from all participants.
: Author MJ is the 2018 GE Healthcare Call for proposal Awardee. Other authors have no relevant financial or non-financial interests to disclose.